The company has substantially improved this course of a innovative treatment for ATTR-CM, employing the compound. Initial clinical data suggests potential improvements for patients suffering by the serious disease. This https://attruby866512.collectblogs.com/86794293/bridgebio-progresses-amyloidosis-treatment-with-the-drug